Back to results

Massachusetts Institute of Technology

Financing methods that drive innovation in biotech and pharmaceuticals : the meagfund [sic] IPO model

Abstract

dc:description.abstract

Current research has shown that a mega fund and securitization approach using debt financing can not only mitigate risk in investments in cancer but can also align research and development in the right direction for new and innovative breakthrough therapies. We propose a new application of this megafund biopharma model - the megafund IPO model. There are almost arbitrage-like opportunities for investors where there are heavily discounted investments opportunities which are generated in IPO's. However, these events driven investments are only for the institutional investor and hence pooling capital into a more scalable mega fund structure could generate returns that are not otherwise possible while encouraging innovation in biomedicine. The investment vehicle is attractive to investors because of the significant amount of alpha that the fund can generate on de-risked basis. Risk is mitigated by the fact that there is an arbitrage like opportunity for the institutional investor in events driven investments for the mispricing of an IPO. We examine a back-testing of ten years examining a long only strategy and later also look at a case study of Monashee Investment Management that currently most closely resembles the megafund IPO model.

Degree

thesis:*
Department dc:contributor.department
Sloan School of Management. Master of Finance Program.
Grantor dc:publisher
Massachusetts Institute of Technology
Year dc:date.issued
2014

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Cho, Harngid
Advisor dc:contributor.advisor
  • Andrew Lo.

Subjects

dc:subject × 1

Rights

dc:rights
Statement dc:rights
  • M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission.
Language dc:language.iso
eng

Identifiers

dc:identifier.*
Handle dc:identifier.uri
http://hdl.handle.net/1721.1/90227
OAI identifier oai:identifier
oai:dspace.mit.edu:1721.1/90227

Chain of custody

source
Harvested from
MIT
Base URL
dspace.mit.edu/oai/request
Last updated
2026-07-22
Source record
OAI-PMH GetRecord
citation

Cho, Harngid. Financing methods that drive innovation in biotech and pharmaceuticals : the meagfund [sic] IPO model. Massachusetts Institute of Technology, 2014. http://hdl.handle.net/1721.1/90227